New Developments in Bacterial, Viral, and Fungal Cutaneous Infections

doi:10.1007/s13671-020-00295-1

Review

. 2020;9(2):152-165.

doi: 10.1007/s13671-020-00295-1. Epub 2020 Mar 5.

New Developments in Bacterial, Viral, and Fungal Cutaneous Infections

Samuel Yeroushalmi¹, Joshua Yoseph Shirazi², Adam Friedman¹

Affiliations

¹ 1The George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Ave NW, Washington, DC 20037 USA.
² 2The University of Maryland, College Park, MD USA.

PMID: 32435525
PMCID: PMC7224073
DOI: 10.1007/s13671-020-00295-1

Review

New Developments in Bacterial, Viral, and Fungal Cutaneous Infections

Samuel Yeroushalmi et al. Curr Dermatol Rep. 2020.

. 2020;9(2):152-165.

doi: 10.1007/s13671-020-00295-1. Epub 2020 Mar 5.

Authors

Samuel Yeroushalmi¹, Joshua Yoseph Shirazi², Adam Friedman¹

Affiliations

¹ 1The George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Ave NW, Washington, DC 20037 USA.
² 2The University of Maryland, College Park, MD USA.

PMID: 32435525
PMCID: PMC7224073
DOI: 10.1007/s13671-020-00295-1

Abstract

Purpose of review: This review highlights clinically relevant updates to common and significant bacterial, viral, and fungal cutaneous infection within the past 5 years. Recent developments are presented so that the clinician may provide evidence-based, high-quality patient care.

Recent findings: New resistance patterns in cutaneous pathogens have recently emerged as a result of inappropriate antimicrobial use. Several new FDA-approved antimicrobials have been approved to treat such infections, including multi-drug resistant pathogens. Several organizational guidelines for cutaneous infection management have been updated with new recommendations for screening, diagnostic, and treatment strategies.

Summary: Clinicians should be aware of the most recent evidence and guidelines for the management of cutaneous infections in order to reduce the emergence of antimicrobial resistance and most effectively treat their patients.

Keywords: Antibiotic resistance; Cutaneous infections; Developments; Emerging infections; Guideline updates; Infectious dermatology.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestThe authors declare no conflict of interest.

Cited by

Unfolded protein responses: Dynamic machinery in wound healing.
Minjares M, Thepsuwan P, Zhang K, Wang JM. Minjares M, et al. Pharmacol Ther. 2025 Mar;267:108798. doi: 10.1016/j.pharmthera.2025.108798. Epub 2025 Jan 17. Pharmacol Ther. 2025. PMID: 39826569 Review.
Antimicrobial Management of Skin and Soft Tissue Infections among Surgical Wards in South Africa: Findings and Implications.
Makwela AB, Grootboom WM, Abraham V, Witika B, Godman B, Skosana PP. Makwela AB, et al. Antibiotics (Basel). 2023 Jan 31;12(2):275. doi: 10.3390/antibiotics12020275. Antibiotics (Basel). 2023. PMID: 36830186 Free PMC article.
Comparative analysis of the distribution and antifungal susceptibility of yeast species in cat facial hair and human nails.
Yurayart C, Niae S, Limsivilai O, Thengchaisri N, Sattasathuchana P. Yurayart C, et al. Sci Rep. 2024 Jun 26;14(1):14726. doi: 10.1038/s41598-024-65730-w. Sci Rep. 2024. PMID: 38926524 Free PMC article.
Analysis of Types of Skin Lesions and Diseases in Everyday Infectious Disease Practice-How Experienced Are We?
Skuhala T, Trkulja V, Rimac M, Dragobratović A, Desnica B. Skuhala T, et al. Life (Basel). 2022 Jun 29;12(7):978. doi: 10.3390/life12070978. Life (Basel). 2022. PMID: 35888068 Free PMC article.

References

1. Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clin Infect Dis. 2019;68(Suppl 3):S193–S199. - PMC - PubMed
1. Esposito S, Noviello S, Leone S. Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis. 2016;29(2):109–115. - PubMed
1. Lee GC, Boyd NK, Lawson KA, Frei CR. Incidence and cost of skin and soft tissue infections in the United States. Value Health. 2015;(18) [Internet]. [cited 2019 Oct 20]. Available from: https://www.valueinhealthjournal.com/article/S1098-3015(15)01481-3/abstract.
1. Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4. Philadelphia: Elsevier Saunders; 2017. Bacterial diseases; pp. 1187–1120.
1. Pfalzgraff A, Brandenburg K, Weindl G. Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol. 2018;9 [Internet]. [cited 2019 Sep 2]. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2018.00281/full. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

[1] Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clin Infect Dis. 2019;68(Suppl 3):S193–S199. - PMC - PubMed

[2] Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clin Infect Dis. 2019;68(Suppl 3):S193–S199. - PMC - PubMed

[3] Esposito S, Noviello S, Leone S. Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis. 2016;29(2):109–115. - PubMed

[4] Esposito S, Noviello S, Leone S. Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis. 2016;29(2):109–115. - PubMed

[5] Lee GC, Boyd NK, Lawson KA, Frei CR. Incidence and cost of skin and soft tissue infections in the United States. Value Health. 2015;(18) [Internet]. [cited 2019 Oct 20]. Available from: https://www.valueinhealthjournal.com/article/S1098-3015(15)01481-3/abstract.

[6] Lee GC, Boyd NK, Lawson KA, Frei CR. Incidence and cost of skin and soft tissue infections in the United States. Value Health. 2015;(18) [Internet]. [cited 2019 Oct 20]. Available from: https://www.valueinhealthjournal.com/article/S1098-3015(15)01481-3/abstract.

[7] Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4. Philadelphia: Elsevier Saunders; 2017. Bacterial diseases; pp. 1187–1120.

[8] Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4. Philadelphia: Elsevier Saunders; 2017. Bacterial diseases; pp. 1187–1120.

[9] Pfalzgraff A, Brandenburg K, Weindl G. Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol. 2018;9 [Internet]. [cited 2019 Sep 2]. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2018.00281/full. - DOI - PMC - PubMed

[10] Pfalzgraff A, Brandenburg K, Weindl G. Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol. 2018;9 [Internet]. [cited 2019 Sep 2]. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2018.00281/full. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

New Developments in Bacterial, Viral, and Fungal Cutaneous Infections

Affiliations

New Developments in Bacterial, Viral, and Fungal Cutaneous Infections

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous